Results 151 to 160 of about 13,147 (207)

Use of and Barriers to Subcutaneous Apomorphine Pen Injections in Parkinson's Disease: A Survey by the French NS-PARK Network. [PDF]

Mov Disord Clin Pract
Aubignat M, Khelifi F, Rascol O, NS‐PARK/FCRIN Network.   +3 more
europepmc   +1 more source

Timing of device-aided therapy initiation in Parkinson's disease: reference estimates for healthcare planning and biological heterogeneity. [PDF]

Clin Park Relat Disord
Ledingham D, Stewart CB, Sathyanarayana S, Foster V, Iredale R, Galley D, Baker MR, Pavese N.   +7 more
europepmc   +1 more source

Acute Inflammatory Demyelinating Polyradiculoneuropathy-like Associated with Subcutaneous Foslevodopa-Foscarbidopa: First Report. [PDF]

Mov Disord
Cochez H, Cazenave C, Castagnet C, Balguerie L, Acket B, Fabbri M, Ory-Magne F.   +6 more
europepmc   +1 more source

Paroxysmal abdominalgia as a non-motor wearing off phenomenon in Parkinson's disease. A case series and literature review. [PDF]

Clin Park Relat Disord
Bin Khunayfir A, Factor SA.
europepmc   +1 more source

Assessing Eligibility for Apomorphine Therapy in Parkinson's Disease: The Telemonitoring Potential. [PDF]

Mov Disord Clin Pract
Niruban A, Dostal V, Mutimer A, Tsamis K, Kontaxis S, Kostikis N, Kanellos F, Ntanis A, Rigas G, Konitsiotis S.   +9 more
europepmc   +1 more source

Measurement of Glutamate Suppression in a 6-OHDA-Induced Dopamine Deficiency Rat Model Following Acute Single-Dose L-DOPA Using GluCEST/MRS. [PDF]

Biomedicines
Nakano T, Bono K, Ueda J, Ohmi M, Saito S.   +4 more
europepmc   +1 more source

Targeting the hypothalamic a11 nucleus to treat parkinsonian-like nociceptive impairments. [PDF]

NPJ Parkinsons Dis
Charles KA, Bouali-Benazzouz R, Naudet F, Aby F, Fossat P, Benazzouz A.   +5 more
europepmc   +1 more source

No New Relevant Treatment Options for L-DOPA-Induced Dyskinesia from a Clinician's Point of View. [PDF]

Neurol Int
Müller T.
europepmc   +1 more source

A Highly Potent Apomorphine Derivative Enhancing Neurite Outgrowth via Nrf2 Activation. [PDF]

Antioxidants (Basel)
Ishima T, Osaka H, Nagai R, Aizawa K.
europepmc   +1 more source